Treatment of nonmelanoma skin cancer in organ transplant recipients: Review of responses to a survey

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 413-416

  Clayton, Anna S ^b   Stasko, Thomas ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; RETINOID;

CHEMOSURGERY; CRYOSURGERY; CURETTAGE; DESICCATION; E-MAIL; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; NON MELANOMA SKIN CANCER; ORGAN TRANSPLANTATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TREATMENT OUTCOME; UNITED STATES;

EID: 0041856251     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)01835-8     Document Type: Article

References (18)

1. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-9.
2. Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995;33:222-9.
3. Ong CS, Keogh AM, Kissard S, Macdonald PS, Spratt PM, Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999;40:27-34.
4. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986;122:1288-93.
5. Committee on Guidelines of Care, Task Force on Cutaneous Squamous Cell Carcinoma. Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol 1993;28:628-31.
6. Otley CC. Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 2000;26:709-12.
7. Kelly JW, Sabto J, Gurr FW, Bruch F. Retinoids to prevent skin cancer in organ transplant recipients. Lancet 1991;338:1407.
8. Yuan Z, Davis A, Macdonald K, Bailey RR. Use of acitretin for the skin complications in renal transplant recipients. N Z Med J 1995;108:255-6.
9. Bavinck JNB, Tieben LM, Van Der Woude FJ, Tegzess AM, Hermans J, Schegget JT, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind placebo-controlled study. J Clin Oncol 1995;13:1933-8.
10. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999;140:656-60.
11. Shuttleworth D, Marks R, Grifffin PJA, Salaman JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988;257:717-24.
12. Rook AH, Jaworsky C, Nguyen T, Grossman RA, Wolfe JT, Witmer WK, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplant 1995;59:714-9.
13. Thai KE, Sinclair RD. Treatment of Bowen's disease of the penis with imiquimod. J Am Acad Dermatol 2002;46:470-1.
14. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17.
15. Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier in imiquimod 5% cream. J Am Acad Dermatol 2000;43:555-6.
16. Stockfleth E, Meyer T, Benningoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001;144:1050-3.
17. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-flourouracil therapy. Dermatol Surg 2002;27:561-4.
18. Dahl MV. Imiquimod: a cytokine inducer. J Am Acad Dermatol 2002;47 (4 Suppl):S205-8.